Coffee consumption delays the hepatitis and suppresses the inflammation related gene expression in the Long-Evans Cinnamon rat.

Abstract

BACKGROUND AND AIMS:

Large-scale epidemiological studies have shown that drinking more than two cups of coffee per day reduces the risks of hepatitis and liver cancer. However, the heterogeneity of the human genome requires studies of experimental animal models with defined genetic backgrounds to evaluate the coffee effects on liver diseases. We evaluated the efficacy of coffee consumption with one of experimental animal models for human disease.

METHOD:

We used the Long Evans Cinnamon (LEC) rat, which onsets severe hepatitis and high incidence of liver cancer, due to the accumulation of copper and iron in livers caused by the genetic mutation in Atp7B gene, and leading to the continuous oxidative stress. We determined the expression of inflammation related genes, and amounts of copper and iron in livers, and incidence of the pre-neoplastic foci in the liver tissue of LEC rats.

RESULTS:

Coffee administration for 25 weeks delayed the occurrence of hepatitis by two weeks, significantly improved survival, reduced the expression of inflammatory cytokines, and reduced the incidence of small pre-neoplastic liver foci in LEC rats. There was no significant difference in the accumulation of copper and iron in livers, indicating that coffee administration does not affect to the metabolism of these metals. These findings indicate that drinking coffee potentially prevents hepatitis and liver carcinogenesis through its anti-inflammatory effects.

CONCLUSION:

This study showed the efficacy of coffee in the prevention of hepatitis and liver carcinogenesis in the LEC model.

• Authors: Masafumi Katayama, Kenichiro Donai, Hiroyuki Sakakibara, Yukiko Ohtomo, Makoto Miyagawa, Kengo Kuroda, Hiroko Kodama, Kazufumi Suzuki, Noriyuki Kasai, Katsuhiko Nishimori, Takafumi Uchida, Kouichi Watanabe, Hisashi Aso, Emiko Isogai, Hideko Sone, Tomokazu Fukuda
• Journal: Clinical nutrition (Edinburgh, Scotland) (Clin Nutr) Vol. 33 Issue 2 Pg. 302-10 (Apr 2014) ISSN: 1532-1983 [Electronic] England
• PMID: 23755843 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2013 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Chemical References

• Cation Transport Proteins
• Cinnamates
• Coffee
• Interleukin-6
• RNA, Messenger
• Smad2 Protein
• Smad2 protein, rat
• Smad3 Protein
• Smad3 protein, rat
• Tumor Necrosis Factor-alpha
• cinnamic acid
• Caffeine
• Copper
• Iron
• Glutathione Transferase
• Alanine Transaminase
• Adenosine Triphosphatases
• Atp7b protein, rat
• Copper-Transporting ATPases

Topics

• Adenosine Triphosphatases (genetics, metabolism)
• Alanine Transaminase (metabolism)
• Animals
• Caffeine (pharmacology)
• Cation Transport Proteins (genetics, metabolism)
• Cinnamates (pharmacology)
• Coffee (chemistry)
• Copper (adverse effects, pharmacokinetics)
• Copper-Transporting ATPases
• Gene Expression (drug effects)
• Glutathione Transferase (metabolism)
• Hepatitis (prevention & control)
• Inflammation (metabolism)
• Interleukin-6 (genetics, metabolism)
• Iron (adverse effects, pharmacokinetics)
• Liver (drug effects, metabolism)
• Liver Neoplasms (chemically induced, prevention & control)
• Male
• Oxidative Stress (drug effects)
• RNA, Messenger (genetics, metabolism)
• Rats
• Rats, Inbred LEC
• Smad2 Protein (genetics, metabolism)
• Smad3 Protein (genetics, metabolism)
• Tumor Necrosis Factor-alpha (genetics, metabolism)